| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.39B | — | +25.6% |
| Cost of Revenue | $342.3M | — | +18.4% |
| Gross Profit | $1.04B | — | +28.1% |
| R&D Expense | $408.3M | — | +22.2% |
| SG&A Expense | $177.0M | — | +7.1% |
| Operating Income | -$30.6M | — | +75.5% |
| Pre-tax Income | $39.1M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.55B | -13.0% | -1.3% |
| Accounts Receivable | $933.9M | -31.4% | +15.5% |
| Current Assets | $6.30B | -15.1% | +3.8% |
| Total Assets | $11.27B | +1.7% | +29.2% |
| Current Liabilities | $4.12B | -1.6% | +25.4% |
| Long-term Debt |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $590.9M | — | +53.8% |
| Capital Expenditures | $97.6M | — | +13.8% |
| Investing Cash Flow | -$994.1M | — | -876.2% |
| Financing Cash Flow | -$195.9M | — | -9279.5% |
| Free Cash Flow | $493.3M | — | +65.3% |
| +143.5% |
| Income Tax | -$6.9M | — | -132.7% |
| Net Income | $27.8M | — | +125.2% |
| EPS (Basic) | $0.11 | — | +125.0% |
| EPS (Diluted) | $0.11 | — | +125.0% |
| $745.8M |
| +0.0% |
| +0.2% |
| Total Liabilities | $6.59B | -0.3% | +26.1% |
| Stockholders' Equity | $4.63B | +4.6% | +34.3% |